You are here

News

January

Number of advanced cell therapy clinical trials per year with perinatal cells
Jan 2017   There are more advanced cell therapy clinical trials with other sources of perinatal cells than there are with cord blood, either cumulatively or by year.
Newborn With Brain Injury Treated With Own Stem Cells Improving
Jan 2017   When he was 12 days old Jack became the youngest person ever to undergo stem cell therapy in Canada and the first person in the country to be treated for HIE with stem cells.

December

Dr. Elisabeth Semple
Dec 2016   Literature review finds umbilical cord clamping at 30-60 secs after term birth ensures safe outcome for baby and adequate cord blood collection.
Rodica Ciubotariu, MD PhD
Dec 2016   Fraction of cord blood collections suitable for transplant goes down by a factor of 7 when cord clamping delay exceeds 1 minute.

November

Correlation between public and family cord blood banks per country in 2015
Nov 2016   Slides from Parent's Guide to Cord Blood Foundation at Phacilitate Cord Blood and Tissue Webinar 16 Nov. 2016. All presentations will be archived.
Babycell cord blood transplant patient Neha with her donor brother
Nov 2016   Neha is now a healthy six year old after a cord blood transplant from her brother thanks to the family cord blood bank Babycell in India.
AmnioChor
Nov 2016   We see rapid growth in AMP-based injectable products being offered in the U.S., and targeted specifically for allogeneic use. Does this meet FDA guidance?

October

Parent's Guide to Cord Blood Foundation logo
Oct 2016   Commerical banks are NOT the dominant source of 2015 funding for Parent's Guide to Cord Blood Foundation.
Phacilitate 2017 Cell & Gene Therapy World
Oct 2016   The newly launched Phacilitate Cord Blood will be part of Phacilitate Cell & Gene Therapy World in Miami January 2017.
AmnioChor
Oct 2016   AmnioChor proposes that amniotic membrane of the placenta (AMP) is a paradigm shifter because a single placenta provides multiple doses for now or later, that can be tissue or cellular therapy, can be autologous, matched allogeneic, or allogeneic therapy.